Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cisplatin + gemcitabine + bevacizumab in advanced or metastatic non-small cell lung cancer
2012-000459-15Phase 4Completed
- Sponsor
- Fundació de Recerca Clínic Barcelona-Institut d’Investigacions Biomèdiques August Pi i Sunyer
- Start
- Mar 2012
- Modality
- Small Molecules, Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of bevacizumab, cisplatin and gemcitabine in non-small cell lung cancer (NSCLC), sponsored by Fundació de Recerca Clínic Barcelona-Institut d’Investigacions Biomèdiques August Pi i Sunyer. Started Mar 2012; status: completed.
02
Drugs
bevacizumabcisplatingemcitabine
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on 2012-000459-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000459-15.